TGFB1 and neoplasm: After TGF-β treatment, Saos-2/MG-63 cells revealed obviously higher consumption of glucose and increased production of lactate (Fig. 2A), suggesting that tumor cells might enhance glycolysis by preferential conversion of pyruvate to lactate instead of oxidation.